BUPEPLANT
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Apr 2021)
What this means for you
This application is over — abandoned 12 Apr 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88427943
- Mark type
- Stylized text
- Filed
- 13 May 2019
- Published for opposition
- 16 Jul 2019
- Abandoned
- 12 Apr 2021
- Attorney of record
- Jennifer Lee Taylor
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
Owner
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
Prosecution history
- 12 Apr 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Apr 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2020 — SOU EXTENSION 2 GRANTED
- 13 Aug 2020 — SOU EXTENSION 2 FILED
- 13 Aug 2020 — SOU TEAS EXTENSION RECEIVED
- 08 Feb 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2020 — SOU EXTENSION 1 GRANTED
- 06 Feb 2020 — SOU EXTENSION 1 FILED
- 06 Feb 2020 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jul 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2019 — PUBLISHED FOR OPPOSITION
- 26 Jun 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jun 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER